BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9157952)

  • 1. Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1).
    Teng B; Ishida B; Forte TM; Blumenthal S; Song LZ; Gotto AM; Chan L
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):889-97. PubMed ID: 9157952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
    Nakamuta M; Chang BH; Zsigmond E; Kobayashi K; Lei H; Ishida BY; Oka K; Li E; Chan L
    J Biol Chem; 1996 Oct; 271(42):25981-8. PubMed ID: 8824235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production.
    Teng B; Blumenthal S; Forte T; Navaratnam N; Scott J; Gotto AM; Chan L
    J Biol Chem; 1994 Nov; 269(47):29395-404. PubMed ID: 7961918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.
    Nakamuta M; Taniguchi S; Ishida BY; Kobayashi K; Chan L
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):747-55. PubMed ID: 9598833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.
    Hughes SD; Rouy D; Navaratnam N; Scott J; Rubin EM
    Hum Gene Ther; 1996 Jan; 7(1):39-49. PubMed ID: 8825867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal perinatal rise in serum cholesterol is inhibited by hepatic delivery of adenoviral vector expressing apolipoprotein B mRNA editing enzyme (Apobec1) in rabbits.
    Wu Y; Teng BB; Brandt ML; Piedra PA; Liu J; Chan L
    J Surg Res; 1999 Jul; 85(1):148-57. PubMed ID: 10383852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
    J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic gene transfer of the catalytic subunit of the apolipoprotein B mRNA editing enzyme results in a reduction of plasma LDL levels in normal and watanabe heritable hyperlipidemic rabbits.
    Greeve J; Jona VK; Chowdhury NR; Horwitz MS; Chowdhury JR
    J Lipid Res; 1996 Sep; 37(9):2001-17. PubMed ID: 8895066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms.
    Srivastava RA
    Mol Cell Biochem; 1996 Feb; 155(2):153-62. PubMed ID: 8700160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA.
    Srivastava RA
    Biochem Biophys Res Commun; 1995 Jul; 212(2):381-7. PubMed ID: 7626051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous expression of apolipoprotein B mRNA editing enzyme and scavenger receptor BI mediated by a therapeutic gene expression system.
    Zhong S; Liu C; Haviland D; Doris PA; Teng BB
    Atherosclerosis; 2006 Feb; 184(2):264-75. PubMed ID: 15979078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary fats and cholesterol on liver lipid content and hepatic apolipoprotein A-I, B, and E and LDL receptor mRNA levels in cebus monkeys.
    Hennessy LK; Osada J; Ordovas JM; Nicolosi RJ; Stucchi AF; Brousseau ME; Schaefer EJ
    J Lipid Res; 1992 Mar; 33(3):351-60. PubMed ID: 1314879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor.
    Kobayashi K; Oka K; Forte T; Ishida B; Teng B; Ishimura-Oka K; Nakamuta M; Chan L
    J Biol Chem; 1996 Mar; 271(12):6852-60. PubMed ID: 8636110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumors.
    Qian X; Balestra ME; Yamanaka S; Borén J; Lee I; Innerarity TL
    Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):1013-20. PubMed ID: 9633945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids.
    Tadin-Strapps M; Peterson LB; Cumiskey AM; Rosa RL; Mendoza VH; Castro-Perez J; Puig O; Zhang L; Strapps WR; Yendluri S; Andrews L; Pickering V; Rice J; Luo L; Chen Z; Tep S; Ason B; Somers EP; Sachs AB; Bartz SR; Tian J; Chin J; Hubbard BK; Wong KK; Mitnaul LJ
    J Lipid Res; 2011 Jun; 52(6):1084-1097. PubMed ID: 21398511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal production rate of apolipoprotein B in LDL receptor-deficient mice.
    Millar JS; Maugeais C; Fuki IV; Rader DJ
    Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):989-94. PubMed ID: 12067909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.
    Hersberger M; Patarroyo-White S; Qian X; Arnold KS; Rohrer L; Balestra ME; Innerarity TL
    Biochem J; 2003 Jan; 369(Pt 2):255-62. PubMed ID: 12374571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice.
    Furbee JW; Francone O; Parks JS
    J Lipid Res; 2002 Mar; 43(3):428-37. PubMed ID: 11893779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
    Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
    J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms.
    Srivastava RA; Averna M; Srivastava N; Pape ME
    Int J Biochem Cell Biol; 2001 Dec; 33(12):1215-26. PubMed ID: 11606258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.